Characteristics of the antiulcerogenic activity of cryopreserved placenta extract in acute and chronic lesions of the stomach

Authors

  • F. V. Hladkykh State Organization «Grigoriev Institute for Medical Radiology and Oncology of the National Academy of Medical Sciences of Ukraine» Kharkiv, Ukraine, Ukraine https://orcid.org/0000-0001-7924-4048
  • I. V. Koshurba State Organization «Grigoriev Institute for Medical Radiology and Oncology of the National Academy of Medical Sciences of Ukraine» Kharkiv, Ukraine, Ukraine https://orcid.org/0000-0002-4595-9245
  • M. O. Chyzh State Organization «Grigoriev Institute for Medical Radiology and Oncology of the National Academy of Medical Sciences of Ukraine» Kharkiv, Ukraine, Ukraine https://orcid.org/0000-0003-0085-296X

DOI:

https://doi.org/10.34287/MMT.1(56).2023.10

Abstract

To date, Ukraine has registered about 5 million patients with ulcer disease, and the market of drugs with proven anti-ulcer activity exceeds 500 names, but the problem of effective therapy is far from being solved. Cryoextract of the placenta attracted our attention as a new domestic biotechnological anti-ulcer agent.

The purpose of the study. To characterize the antiulcer activity of cryoextract of human placenta in acute and chronic ulcerogenesis.

Materials and methods. Studies of antiulcer activity were carried out on 56 male rats weighing 200–220 g in two stages: on the model of acute serotonin ulcerogenesis (28 rats) under the therapeutic and prophylactic regimen of placenta cryoextract and on the model of chronic acetic acid damage to the stomach (28 rats) under the therapeutic regimen application of the specified cryoextract.

Results and discussion. The study showed that the therapeutic and prophylactic injection of the cryoextract of the placenta shows a pronounced antiulcer activity in the model of serotonin-induced gastric damage, which was indicated by a decrease in the ulcer index by 13.7 times compared to a similar indicator in the group of untreated animals and was 0.3 and 4, respectively. 1. Hemorrhagic lesions of the gastric mucosa occurred twice as often against the background of placenta cryoextract administration, respectively, against the background of esomeprazole administration – in 57.1% of rats, and against the background of placenta cryoextract administration – in 28.6% of rats. It was established that the investigated cryoextract has a cytoprotective effect on the mucous membrane of the stomach against the background of acetic acid damage. This was indicated by a statistically significant (p<0.05) decrease in the ulcer index by 30.0% compared to the indicators of untreated animals.

Conclusions. It was established that the cryoextract of the human placenta has pronounced antiulcer activity both in acute and chronic experimental ulcerogenesis, which was indicated by a statistically significant decrease in erosions and ulcers of the gastric mucosa.

References

Sabadishin RO. Gastric ulcer: etiological and pathogenetic causes. Medicine of Ukraine. 2021;7(253):24–7. DOI: https://doi.org/10.37987/1997-9894.2021.7(253).245652.

Bereda G. Peptic Ulcer Disease: Definition, Pathophysiology, and Treatment. Journal of Biomedical and Biological Sciences. 2022; 1 (2): 1–10.

Aumpan N, Mahachai V, Vilaichone RK. Management of Helicobacter pylori infection. An Open Access Journal of Gastroenterology and Hepatology. 2022; 7 (1): 3–15. DOI: https://doi.org/10.1002/jgh3.12843.

Pan SY, Chan MKS, Wong MBF, Klokol D, Chernykh V. Placental therapy: An insight to their biological and therapeutic properties. Journal of Medicine and Therapeutics. 2017;1(3):1–6. DOI: http://doi.org/10.15761/JMT.1000118

Hladkykh F. V. Experimental study of the antiulcer effect of cryopreserved placenta extract on a model of acetylsalicylic acid-induced ulcerogenesis. Current Issues in Pharmacy and Medical Sciences. 2021; 35 (2): 89–94. DOI: https://doi.org/10.2478/cipms-2022-0017

Hladkykh FV. Gastrocytoprotective properties of cryopreserved placenta extract in combined action of low temperatures and inhibition of cyclooxygenase. Acta Facultatis Medicae Naissensis. 2022;39(1):48–56. DOI: https://doi.org/10.5937/afmnai39-33036

Hladkykh FV. Anti-inflammatory properties of diclofenac sodium on the background of combined use with cryopreserved placenta extract in the experiment. Problems of cryobiology and cryomedicine. 2021;31(4):364–7. DOI: https://doi.org/10.15407/cryo31.04.364

Koshurba IV, Chyzh MO, Hladkykh FV, Belochkina IV. Influence of placenta cryoextract on the liver metabolic and functional state in Case of D-galactosamine hepatitis. The Innovative Biosystems and Bioengineering. 2022; 6 (2): 64–67. DOI: https://doi.org/10.20535/ibb.2022.6.2.264774.

Koshurba IV, Hladkykh FV, Chyzh MO, Belochkina IV, Rubleva TV. Hepatotropic effects of triple antiulcer therapy and placenta cryoextract: the role of sex factors in lipoperoxidation. Fiziologichnyi Zhurnal. 2022; 68 (5): 25–32. DOI: https://doi.org/10.15407/fz68.05.025.

Koshurba IV. Study of the effect of cryopreserved placenta extract on the processes of cytolysis and lipid peroxidation in ССl4-induced liver damage. Modern Medical Technology. 2022; 3 (54): 46–54. DOI: https://doi.org/10.34287/MMT.3(54).2022.9.

Vogel HG. ed. Drug Discovery and Evaluation: Pharmacological Assays Berlin, Heidelberg: Springer Berlin Heidelberg 2008; 2071 p.

Zar J.H. Biostatistical analysis (5 ed.). Prentice-Hall, Englewood. 2014; 960 р.

Downloads

Published

2023-03-20

How to Cite

Hladkykh, F. V. ., Koshurba, I. V. ., & Chyzh, M. O. . (2023). Characteristics of the antiulcerogenic activity of cryopreserved placenta extract in acute and chronic lesions of the stomach. Modern Medical Technology, (1), 62–68. https://doi.org/10.34287/MMT.1(56).2023.10

Issue

Section

Original research